Latest Cardiac and Diabetes Advancements from Medtronic Win 2015 'Best of What's New' Awards from Popular Science
November 18 2015 - 9:00AM
World's Smallest
Pacemaker and Investigational Insulin Pump System Recognized Among
the Top 100 Technology Innovations
DUBLIN - November 18, 2015 -
Medtronic plc (NYSE: MDT) today announced that its Micra®
Transcatheter Pacing System (TPS) and Hybrid Closed Loop system
have both earned the 2015 'Best of What's New' award in the health
category by Popular Science, the world's
largest science and technology magazine.
Selected after careful evaluation of thousands of
submissions, the Micra TPS and Hybrid Closed Loop system, which
includes an insulin pump and a continuous glucose monitor sensor,
are among the 100 honorees that represent a significant leap
forward in their respective categories. All winners will be
featured in the magazine's December issue, available now.
At less than one-tenth the size of traditional
pacemakers, the Micra TPS is the world's smallest pacemaker yet
provides the most advanced pacing technology available for
patients. It is cosmetically invisible and small enough to be
delivered with minimally invasive techniques through a catheter,
and implanted directly into the heart. Comparable in size to a
large vitamin, the Micra TPS does not require the use of wires,
known as "leads," to deliver pacing therapy; rather, its flexible
tines attach to the interior of the right ventricle. In the
United States, the Micra TPS is an investigational device and not
yet approved for commercial use. The device was awarded CE Mark
(Conformité Européenne) in April 2015, with approval for 1.5T and
3T full body MRI scanning providing patients with access to the
most advanced imaging diagnostic procedures.
Building on the breakthrough technology in the
MiniMed® 640G system (investigational device in the United States,
commercially available in select countries outside of the United
States), the Hybrid Closed Loop system is designed to automatically
control glucose levels 24 hours a day with less input from people
with diabetes. People using the system will only need to enter
their carbohydrates at mealtime, and calibrate the sensor
periodically, significantly simplifying today's diabetes management
routines. The Hybrid Closed Loop system is an investigational
device and not yet approved for commercial use. The technology is
currently in the first pivotal trial of closed loop technology
conducted in the United States. As Medtronic's largest and longest
at-home closed loop study, this single-arm, multi-center, home and
hotel clinical study will enroll up to 150 patients aged 14-75 with
type 1 diabetes on insulin pump therapy. Additional trial
details, including enrollment information, can be found at
ClinicalTrials.gov (Identifier: NCT02463097).
"The Best of What's New awards honor the
innovations that surprise and amaze us-those that challenge our
view of what's possible in the future," said Cliff Ransom,
Editor-in-Chief of Popular Science. "The award
is Popular Science's top prize, and the 100
winners-chosen from among thousands of nominees-are each a
revolution in their respective fields."
About Best of What's
New
Each year, the editors of Popular Science
review thousands of products in search of the top 100 tech
innovations of the year-breakthrough products and technologies that
represent a significant leap in their categories. The winners, the
Best of What's New, are awarded inclusion in the much-anticipated
December issue of Popular Science, the most
widely read issue of the year since the debut of Best of What's New
in 1988. Best of What's New awards are presented to 100 new
products and technologies in 12 categories: Automotive, Aviation,
Computing, Engineering, Gadgets, Green, Entertainment, Security,
Software, Home, Health and Recreation.
About Popular
Science
Founded in 1872, Popular Science is the
world's largest science and technology magazine; with a circulation
of 1.3 million and 6.8 million monthly readers. Each month, Popular
Science reports on the intersection of science and everyday life,
with an eye toward what's new and why it matters. Popular Science is published by Bonnier Active Media, a
subsidiary of Bonnier Corporation.
About Medtronic
Medtronic plc (www.medtronic.com), headquartered in Dublin,
Ireland, is among the world's largest medical technology, services
and solutions companies - alleviating pain, restoring health and
extending life for millions of people around the world. Medtronic
employs more than 85,000 people worldwide, serving physicians,
hospitals and patients in approximately 160 countries. The company
is focused on collaborating with stakeholders around the world to
take healthcare Further, Together.
Any forward-looking statements
are subject to risks and uncertainties such as those described in
Medtronic's periodic reports on file with the Securities and
Exchange Commission. Actual results may differ materially from
anticipated results.
-end-
Contacts:
Ryan Mathre
Public Relations
Cardiac and Vascular Group
+1-763-514-9625
Pamela Reese
Communications
Diabetes Group
+1-818-576-3398
Ryan Weispfenning
Investor Relations
+1-763-505-4626
This
announcement is distributed by NASDAQ OMX Corporate Solutions on
behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: Medtronic plc via Globenewswire
HUG#1967564
Medtronic (NYSE:MDT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Medtronic (NYSE:MDT)
Historical Stock Chart
From Sep 2023 to Sep 2024